Capital Investment Services Of America Decreased By $442,800 Its Proto Labs (PRLB) Stake; Novavax, Inc. (NVAX) Covered By 4 Bulls

February 13, 2018 - By John Hoffman

Among 12 analysts covering Novavax (NASDAQ:NVAX), 4 have Buy rating, 0 Sell and 8 Hold. Therefore 33% are positive. Novavax had 26 analyst reports since August 11, 2015 according to SRatingsIntel. On Friday, September 16 the stock rating was maintained by FBR Capital with “Outperform”. The firm has “Buy” rating by FBR Capital given on Thursday, January 11. The firm has “Buy” rating given on Tuesday, October 31 by Citigroup. Ladenburg Thalmann downgraded Novavax, Inc. (NASDAQ:NVAX) on Friday, September 16 to “Neutral” rating. The firm has “Neutral” rating given on Friday, September 16 by JP Morgan. The company was upgraded on Wednesday, August 9 by Ladenburg Thalmann. The firm has “Neutral” rating by Citigroup given on Friday, September 16. Piper Jaffray maintained Novavax, Inc. (NASDAQ:NVAX) rating on Tuesday, September 19. Piper Jaffray has “Hold” rating and $1.5 target. Cantor Fitzgerald maintained the stock with “Hold” rating in Friday, July 21 report. Chardan Capital Markets maintained the shares of NVAX in report on Tuesday, September 20 with “Neutral” rating. See Novavax, Inc. (NASDAQ:NVAX) latest ratings:

11/01/2018 Broker: FBR Capital Rating: Buy New Target: $10.0 Maintain
11/01/2018 Broker: Ladenburg Rating: Buy New Target: $2.5 Maintain
05/01/2018 Broker: B. Riley & Co Rating: Buy New Target: $2.25 Initiates Coverage On
05/01/2018 Broker: FBR Capital Rating: Buy New Target: $2.25
19/12/2017 Broker: Citigroup Old Rating: Buy New Rating: Neutral Downgrade
14/11/2017 Broker: Cantor Fitzgerald Rating: Hold New Target: $2.0 Maintain
08/11/2017 Broker: Cantor Fitzgerald Rating: Hold New Target: $2.0 Maintain
31/10/2017 Broker: Citigroup Old Rating: Neutral New Rating: Buy Upgrade
06/10/2017 Broker: Seaport Global Rating: Neutral Initiates Coverage On
19/09/2017 Broker: Piper Jaffray Rating: Hold New Target: $1.5 Maintain

Capital Investment Services Of America Inc decreased Proto Labs Inc (PRLB) stake by 3.79% reported in 2017Q3 SEC filing. Capital Investment Services Of America Inc sold 5,535 shares as Proto Labs Inc (PRLB)’s stock rose 14.66%. The Capital Investment Services Of America Inc holds 140,569 shares with $11.29M value, down from 146,104 last quarter. Proto Labs Inc now has $2.82B valuation. The stock decreased 0.14% or $0.15 during the last trading session, reaching $105.75. About 283,519 shares traded or 67.64% up from the average. Proto Labs, Inc. (NYSE:PRLB) has risen 6.14% since February 13, 2017 and is uptrending. It has underperformed by 10.56% the S&P500.

Novavax, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. The company has market cap of $649.69 million. The firm develops respiratory syncytial virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III development stage; older adults in Phase II development stage; and children six months to five years of age in Phase I development stage. It currently has negative earnings. It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates.

Investors sentiment increased to 1.26 in 2017 Q3. Its up 0.24, from 1.02 in 2017Q2. It improved, as 10 investors sold Novavax, Inc. shares while 29 reduced holdings. 14 funds opened positions while 35 raised stakes. 113.94 million shares or 6.86% less from 122.33 million shares in 2017Q2 were reported. Artal Grp Sa has invested 0.01% of its portfolio in Novavax, Inc. (NASDAQ:NVAX). Baker Bros Advsr Limited Partnership accumulated 2.00M shares. The Montana-based Da Davidson has invested 0% in Novavax, Inc. (NASDAQ:NVAX). 844,693 were reported by Tiaa Cref Invest Management Limited Liability Company. Tekla Mgmt Limited Liability holds 0.02% or 571,000 shares. Moreover, Teacher Retirement System Of Texas has 0% invested in Novavax, Inc. (NASDAQ:NVAX). Invesco Limited reported 219,343 shares or 0% of all its holdings. Commonwealth Equity Serv reported 298,539 shares stake. Gsa Prtn Llp holds 0.09% or 1.12 million shares in its portfolio. State Of Wisconsin Board accumulated 200,000 shares. Swiss Financial Bank has 447,050 shares. Franklin Res holds 0% or 3.43 million shares. Ameriprise Fincl reported 2.76M shares. Royal Retail Bank Of Canada holds 0% of its portfolio in Novavax, Inc. (NASDAQ:NVAX) for 40,935 shares. Employees Retirement Association Of Colorado reported 60,532 shares.

The stock increased 1.52% or $0.03 during the last trading session, reaching $2.01. About 4.80M shares traded. Novavax, Inc. (NASDAQ:NVAX) has declined 79.61% since February 13, 2017 and is downtrending. It has underperformed by 96.31% the S&P500.

Since August 31, 2017, it had 1 buy, and 1 sale for $173,620 activity. Another trade for 12,784 shares valued at $11,250 was bought by Glenn Gregory M. $184,870 worth of Novavax, Inc. (NASDAQ:NVAX) shares were sold by YOUNG JAMES F.

Among 8 analysts covering Proto Labs (NYSE:PRLB), 3 have Buy rating, 0 Sell and 5 Hold. Therefore 38% are positive. Proto Labs had 15 analyst reports since August 26, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Thursday, October 26 by Piper Jaffray. The rating was maintained by Needham on Thursday, October 26 with “Hold”. Craig Hallum maintained the stock with “Hold” rating in Monday, November 27 report. As per Wednesday, May 11, the company rating was initiated by FBR Capital. Dougherty & Company downgraded the shares of PRLB in report on Wednesday, August 31 to “Sell” rating. Dougherty & Company upgraded Proto Labs, Inc. (NYSE:PRLB) on Tuesday, June 27 to “Neutral” rating. The stock of Proto Labs, Inc. (NYSE:PRLB) earned “Buy” rating by Canaccord Genuity on Thursday, October 15. The rating was maintained by Piper Jaffray on Friday, October 13 with “Hold”. On Friday, April 29 the stock rating was downgraded by Stephens to “Equal-Weight”. Piper Jaffray maintained Proto Labs, Inc. (NYSE:PRLB) rating on Wednesday, December 13. Piper Jaffray has “Hold” rating and $84.0 target.

Since December 11, 2017, it had 0 buys, and 2 selling transactions for $430,523 activity. Shares for $379,148 were sold by Bodor Robert. Gawlick Rainer also sold $51,375 worth of Proto Labs, Inc. (NYSE:PRLB) on Tuesday, January 2.